Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?

O Rixe, T Fojo - Clinical cancer research, 2007 - AACR
Since the discovery of conventional chemotherapy and the development of new target-
based agents, the importance of cytostasis in anticancer activity has been debated. This …

Targeting the disordered C terminus of PTP1B with an allosteric inhibitor

N Krishnan, D Koveal, DH Miller, B Xue… - Nature chemical …, 2014 - nature.com
PTP1B, a validated therapeutic target for diabetes and obesity, has a critical positive role in
HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B …

[HTML][HTML] A spatial model of tumor-host interaction: application of chemotherapy

P Hinow, P Gerlee, LJ McCawley… - Mathematical …, 2009 - ncbi.nlm.nih.gov
In this paper we consider chemotherapy in a spatial model of tumor growth. The model,
which is of reaction-diffusion type, takes into account the complex interactions between the …

The contribution of age structure to cell population responses to targeted therapeutics

P Gabriel, SP Garbett, V Quaranta, DR Tyson… - Journal of theoretical …, 2012 - Elsevier
Cells grown in culture act as a model system for analyzing the effects of anticancer
compounds, which may affect cell behavior in a cell cycle position-dependent manner. Cell …

Physiologically based mathematical models to optimize therapies against metastatic colorectal cancer: a mini-review

A Ballesta, J Clairambault - Current pharmaceutical design, 2014 - ingentaconnect.com
Understanding and improving the effects of combined drug treatments in metastatic
colorectal Cancer (mCRC) is a multidisciplinary and multiscale problem, that can benefit …

Modelling physiological and pharmacological control on cell proliferation to optimise cancer treatments

J Clairambault - Mathematical Modelling of Natural Phenomena, 2009 - cambridge.org
This review aims at presenting a synoptic, if not exhaustive, point of view on some of the
problems encountered by biologists and physicians who deal with natural cell proliferation …

Age-structured cell population model to study the influence of growth factors on cell cycle dynamics.

F Billy, J Clairambault, F Delaunay, CA Feillet… - Mathematical …, 2012 - hal.science
Cell proliferation is controlled by many complex regulatory networks. Ourpurpose is to
analyse, through mathematical modeling, the effects of growth factors on the dynamics of the …

[HTML][HTML] Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor …

A Vazquez-Martin, C Oliveras-Ferraros, R Colomer… - Annals of oncology, 2008 - Elsevier
Background Discovery of key proliferative and/or survival cascades closely linked to the
biological effects of human epidermal growth factor receptor (HER) 1 (erbB-1) and/or HER2 …

Optimisation of cancer drug treatments using cell population dynamics

F Billy, J Clairambault, O Fercoq - Mathematical Methods and Models in …, 2012 - Springer
Cancer is primarily a disease of the physiological control on cell population proliferation.
Tissue proliferation relies on the cell division cycle: one cell becomes two after a sequence …

Microbiota source impact in vitro metabolite colonic production and anti-proliferative effect of spent coffee grounds on human colon cancer cells (HT-29)

AM Hernández-Arriaga, BD Oomah… - Food Research …, 2017 - Elsevier
Human gut flora-mediated non-digestible fraction of spent coffee grounds (hgf-NDSCG) was
evaluated for its chemopreventive effect and molecular mechanisms involved on human …